Home›Companies›Healthcare›InterVene

InterVene, Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 7, 2023·Suggest an edit

About InterVene

InterVene is a private company based in South San Francisco, California. It has reported $11,093,651 raised in four offerings on Form D since March 2015. Its chief executive is Jeffrey Elkins.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 21, 2023Mar 7, 2023$1,504,488of $3.0M target6$250KDebt, Options, Securities on exerciseRule 506(b)Form D ↗
Feb 21, 2023Mar 7, 2023$1,504,488of $3.0M target6$250KDebt, Options, Securities on exerciseRule 506(b)Form D ↗
May 11, 2017Jun 7, 2017$2,160,944of $3.0M target17$127KDebt, Options, Securities on exerciseRule 506(b)Form D ↗
Mar 16, 2015Mar 19, 2015$5,923,731of $7.2M target52$113KEquityRule 506(b)Form D ↗
Total, four offerings$11,093,651

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on InterVene's Form D filed Mar 7, 2023.

GG
Fletcher Wilson
Fletcher Wilson
Director
Also a founder and CEO, director at Throne.
JS
AB
Adam Berman
Director
CM
Catherine Matthes
Executive officer
JB
Joe Biller
Director
JE
Jeffrey Elkins
CEO and director

Earlier filings also listed Thomas Fogarty (director, last listed Jun 2017), Mel Schatz (director, last listed Jun 2017) and Evan Ng (secretary, last listed Jun 2017).

Sources

  1. SECInterVene, Inc. filing history